Observational Study
Copyright ©The Author(s) 2021.
World J Cardiol. Aug 26, 2021; 13(8): 372-380
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.372
Table 1 Baseline characteristics
Characteristics
All
T2DM without AF
Incident AF
P value
N/n (%)2733927281 (99.8)48 (0.2)
Age (yr, mean ± SD)60.7 ± 10.560.7 ± 10.565.9 ± 9.90.001
Male, n (%)8518 (31.2)8499 (31.1)19 (39.6)0.21
Duration of T2DM (yr, mean ± SD)7.1 ± 4.87.1 ± 4.86.6 ± 3.40.46
Body mass index (kg/m2, mean ± SD)25.6 ± 4.525.6 ± 4.524.8 ± 4.50.24
Smoking, n (%)1084 (4.0)1080 (4.0)4 (8.5)0.12
Comorbidity and complication, n (%)
Hypertension19840 (72.6)19801 (72.6)39 (81.3)0.18
Ischemic heart disease947 (3.5)939 (3.4)8 (16.7)< 0.001
Cerebrovascular disease666 (2.4)661 (2.4)5 (10.4)0.01
Diabetic retinopathy2008 (7.4)2005 (7.4)3 (6.7)1.00
Medication, n (%)
Insulin use5848 (21.4)5840 (21.4)8 (16.7)0.42
Antiplatelets or anticoagulants16321 (60.1)16285 (60.1)36 (75.0)0.04
eGFR (mL/min/1.73 m2, mean ± SD)66.9 ± 25.966.9 ± 25.960.5 ± 25.70.09
CHA2DS2VASc score (mean ± SD)2.9 ± 1.02.9 ± 1.03.7 ± 1.40.001